Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

NCT05862337 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Anlotinib hydrochloride capsules, Penpulimab injection
DRUG: Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.